Antipsychotics and Identity: The Adverse Effect No One is Talking About

M Conneely, D Roe, I Hasson-Ohayon… - … Mental Health Journal, 2024 - Springer
People who take antipsychotics, and people who are prescribed antipsychotics without
taking them, experience effects which are not frequently discussed: effects on their identity …

[HTML][HTML] Psychopharmaceutical enhancers: Enhancing identity?

I Bolt, M Schermer - Neuroethics, 2009 - Springer
The use of psychopharmaceuticals to enhance human mental functioning such as cognition
and mood has raised a debate on questions regarding identity and authenticity. While some …

Psychosis and identity: Alteration or loss?

T Gergel, E Iacoponi - Journal of evaluation in clinical practice, 2017 - Wiley Online Library
The onset of psychotic disorders often brings major changes to an individual, which, for
some, are never fully reversed and remain a dominant force. Despite such changes, the …

From being an illness to being a person: identity, acceptance and control among outpatients with schizophrenia treated with atypical medications.

Y Korman - 2004 - library-archives.canada.ca
Unlike other enduring illnesses (such as cancer or diabetes) which are considered to be
illnesses that one'has', schizophrenia is thought to be an illness that one'is' or'becomes' …

[HTML][HTML] Antipsychotic Discontinuation through the Lens of Epistemic Injustice

H Speyer, LF Eplov, D Roe - Community Mental Health Journal, 2024 - Springer
Community Mental Health Journal is essential to acknowledge that certain individuals,
under specific circumstances, may indeed struggle to deliver trustworthy information due to …

Experiences and narratives–Drug users with antisocial personality disorder retelling the process of treatment and change

B Thylstrup, M Hesse, M Thomsen… - … , Prevention and Policy, 2015 - Taylor & Francis
Aim: The aim of this study was to explore the value of adding a narrative perspective when
listening to how two drug users with comorbid antisocial personality disorder (ASPD) …

What's in it for me? The utility of psychiatric treatments from the perspective of the person in recovery

L Davidson, R Miller, E Flanagan - Epidemiology and Psychiatric …, 2008 - cambridge.org
The aim of this contribution is to explore how different treatments are experienced from the
perspective of individu-als with mental illnesses. We used data drawn from qualitative …

Becoming adherent to antipsychotics: a qualitative study of treatment-experienced schizophrenia patients

C Tranulis, D Goff, DC Henderson… - Psychiatric …, 2011 - Am Psychiatric Assoc
Objective: Discontinuation of antipsychotic medication is a pervasive clinical problem in the
treatment of patients suffering from psychosis. The aim of this study was to complement a …

[HTML][HTML] Managing non-adherence and the 3 Cs: collaboration, cash and coercion

AS David - World Psychiatry, 2013 - ncbi.nlm.nih.gov
The review by Kane et al illustrates eloquently just how much we have learned about
adherence and nonadherence to treatment interventions in medicine as a whole as well as …

Unchaining people with mental disorders: medication is not the solution

V Patel, K Bhui - The British Journal of Psychiatry, 2018 - cambridge.org
Chaining of people with mental disorders, and their incarceration and abuse in prisons or
mental hospitals, is an affront to psychiatry and humanity. Although mental healthcare …